• Mon, December 2, 2024

by: Thomas Matters

Boeing: Selling $83 Billion Of Inventories Is Essential To A Stronger Buy

Boeing aims to cut $83B in inventories and streamline operations. Find out why BA stock is set to benefit from these strategic changes.

by: Thomas Matters

Hedge funds profit from 'Trump trades' around US election

by: Thomas Matters

Thesis Gold Upsizes Previously-Announced Private Placement To $10 Million

by: Thomas Matters

Buying ASX 200 dividend stocks? Here's what to expect in 2025

Should I buy ASX 200 dividend stocks in 2025? The post Buying ASX 200 dividend stocks? Here's what to expect in 2025 appeared first on The Motley Fool Australia.

by: Thomas Matters

Why Wolfspeed Stock Is Soaring Today

by: Thomas Matters

1 Historically Cheap Stock-Split Stock to Buy Hand Over Fist in December and 1 Potentially Troubled Artificial Intelligence (AI) Stock Split to Avoid

While the artificial intelligence (AI) revolution has been undeniably important in lifting the broader market, it would be unwise to ignore the role stock-split euphoria has played in pushing a number of market-leading businesses higher this year.

by: Thomas Matters

Peter Brandt Hints At Litecoin Price Rally To $420 Mirroring XRP's Path

Peter Brandt hints at a potential Litecoin price rally to $420, mirroring XRP's recent surge, amid renewed market optimism and strong trading volume.

by: Thomas Matters

Nvidia Bought 6 Artificial Intelligence (AI) Stocks, but This 1 Has Soared the Most

Nvidia is spreading some of its wealth by investing in a portfolio of other artificial intelligence companies.

by: Thomas Matters

Here's Why Fiserv (FI) is a Strong Growth Stock

by: Thomas Matters

Warren Buffett Owns 1 Vanguard ETF That Could Be Poised to Plunge, According to a Top Wall Street Analyst

But the picture could soon change. Buffett owns one Vanguard ETF that could be poised to plunge, according to a top Wall Street analyst. Buffett hasn't pressed the "easy button" by investing heavily in ETFs. Nearly all of Berkshire's $300 billion-plus equity portfolio is still in individual stocks. However, two ETFs remain in the mix.

by: Thomas Matters

Muni Bond Funds Are Attractive Now If You Have Large Taxable Assets

Muni bond funds and ETFs are offering tempting yields vs. other fixed income offerings. Check out the issues while considering investing in muni funds or ETFs.

by: Thomas Matters

Stock Market News: Dow Drops, Nasdaq Heads to New Record

by: Thomas Matters

TBG: A New And Promising Dividend Growth ETF

TBG Dividend Focus ETF is a concentrated ETF with value and growth characteristics. Learn why TBG should be on your radar for dividend growth investments.

by: Thomas Matters

Why Rio Tinto shares are my top ASX mining sector buy

Let's dig into what makes Rio Tinto such an attractive miner to own. The post Why Rio Tinto shares are my top ASX mining sector buy appeared first on The Motley Fool Australia.

by: Thomas Matters

Unusually active option classes on open December 2nd

by: Thomas Matters

Here's Why News Corp. (NWSA) is a Strong Momentum Stock

by: Thomas Matters

Xplore Appoints Telecom Industry Leader Brent Johnston as CEO

by: Thomas Matters

Looking for an ASX dividend stock with a yield of over 10%? I'd buy this one

This stock is offering huge payouts and I like it. The post Looking for an ASX dividend stock with a yield of over 10%? I'd buy this one appeared first on The Motley Fool Australia.

by: Thomas Matters

Why Is Merck & Co., Inc. (MRK) Among the Stocks Ray Dalio's Bridgewater Is Crazy About?

We recently compiled a list of the Billionaire Ray Dalio's Bridgewater Is Crazy About These 15 Stocks. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other stocks Ray Dalio's Bridgewater is crazy about.
  • Tue, December 3, 2024

by: Thomas Matters

Fidelity International announces India appointments, Jetly to lead tech ops

Sally Nelson, Chief People Officer at Fidelity International, said these appointments will lead Fidelity International's growth and innovation in India, as well as their leadership potential for the global business.

by: Thomas Matters

Stock market today: Stocks climb to record highs as Fed members point to December rate cut

"At present, I lean toward supporting a cut to the policy rate at our December meeting," Christopher Waller, a Federal Reserve governor, said Monday.

by: Thomas Matters

Is Ford a Millionaire-Maker Stock?

Either way, Ford is not a millionaire maker because neither scenario looks likely to generate market-beating equity growth. Long-term investors should probably sell or avoid the stock.

by: Thomas Matters

Hims & Hers price target raised to $38 from $28 at Canaccord

by: Thomas Matters

SBI MF launches multi-factor quant fund to target momentum, quality, growth

According to the fund house, the model will identify stocks as momentum, value, quality, or growth based on data

by: Thomas Matters

SBI MF launches Quant fund based on four factors

by: Thomas Matters

XLI: Industrials Sector Continues Its Quiet Leadership

XLI is a well-diversified ETF within the industrials sector, avoiding heavy reliance on a few stocks. Read why I remain neutral on the fund.

by: Thomas Matters

Stock Splits Matter: Here's What's Coming in December

Here is a look at why companies split their stocks and those splits matter. Plus, upcoming stock splits to watch from Entergy, Wipro and more.

by: Thomas Matters

Bitcoin Spiked After Trump Election Win. These 4 Crypto Stocks Are Doing Even Better.

Bitcoin went on a record-breaking run after Donald Trump won the U.S. presidential election—but shares in some companies that make money out of the crypto's surging price have performed even better. The large-cap token has surged on the expectation that Trump will slash digital-asset regulations,

by: Thomas Matters

Got $1,000? 2 Top Growth Stocks to Buy Now

by: Thomas Matters

Broker vs. Market Maker: What's the Difference?

A broker makes money by bringing together assets to buyers and sellers, while a market maker helps to create a market for investors to buy or sell securities.

by: Thomas Matters

Bitcoin Price Today Trades at $95K, US Moves Nearly $2B BTC

by: Thomas Matters

The Stock Market Is Around All-Time Highs: Is It Time to Sell?

By using this type of strategy, you'll naturally end up buying fewer shares of your favorite stocks and ETFs when the market is high, and more shares when prices are lower. Over time, you'll end up with a mathematically favorable average cost, and it completely takes market timing out of the equation.

by: Thomas Matters

Billionaire Philippe Laffont Is Dumping Shares of Artificial Intelligence (AI) Leaders Nvidia and AMD in Favor of a Tasty Stock-Split Stock

by: Thomas Matters

Here's Why Sony (SONY) is a Strong Value Stock

by: Thomas Matters

Vitasoy International: Turning Bullish On Margin Expansion And Shareholder Stake Increase

Vitasoy's (VTSYF) operating margin expanded meaningfully by +2.5 percentage points YoY in 1H FY 2025. Read why I upgrade the stock from hold to buy.

by: Thomas Matters

Japan's Investment Landscape: Opportunities Amid Transformation

Japan's recent political shifts, coupled with ongoing corporate governance reforms, create a dynamic investment environment with opportunities for strategic, long-term growth.

by: Thomas Matters

Why NuScale Power Stock Slumped Today

by: Thomas Matters

Stock market today: Rising tech stocks pull Wall Street to another record

by: Thomas Matters

This Vanguard ETF Is Up 32% in 2024. Here's Why It's a Simple Way to Invest in Google Parent Alphabet, Meta Platforms, Netflix, and Disney.

The S&P 500 (SNPINDEX: ^GSPC) is up 26.8% through Dec. 2, and certain sectors are doing even better. The Communication Services sector, for instance, is up 34.2% so far in 2024. Investment management firm Vanguard has an exchange-traded fund (ETF) that tracks the performance of the S&P 500's communications sector.

by: Thomas Matters

The Stock Market Has Done This Just 10 Times in 30 Years, and It May Signal a Big Move in 2025

The Motley Fool reaches millions of people every month through our premium investing solutions, free guidance and market analysis on Fool.com, personal finance education, top-rated podcasts, and non-profit The Motley Fool Foundation.

by: Thomas Matters

Robinhood Is Taking on Charles Schwab and Fidelity. What It Means for the Stock.

The company's latest acquisition positions it to challenge incumbents Charles Schwab and Fidelity on a new front.

by: Thomas Matters

What is Cryptocurrency and How Does it Work?

Learn about what is cryptocurrency, its types, and how to buy and store cryptocurrency in this simple guide to digital currencies.

by: Thomas Matters

A 7% dividend yield but down 16%! Is this mining giant a no-brainer?

This FTSE 100 mining titan has taken quite a tumble, but the dividend yield's now high, and long-term tailwinds might help steer it back on track.

by: Thomas Matters

Lululemon Athletica: Strong Growth Prospects Driven by Chinese Market and E-commerce Expansion

by: Thomas Matters

Jeff Bezos is betting millions on a Nvidia rival

Billionaire Jeff Bezos is throwing his weight behind a computing company that's coming for Nvidia's (NVDA) dominance of the artificial intelligence chip market.

by: Thomas Matters

An active 'ethical' MF scheme comes to market after 15 years. Chirag Mehta of Quantum MF explains trigger

Many investors expressed interest in aligning their investments with their values. This inspired us to explore the creation of a fund tailored to these principles, explains Mehta.

by: Thomas Matters

Top 10 mutual funds to invest in December 2024

by: Thomas Matters

2 fantastic ASX growth stocks to buy and hold for 10 years

Why Is Merck & Co., Inc. (MRK) Among the Stocks Ray Dalio's Bridgewater Is Crazy About?

We recently compiled a list of the Billionaire Ray Dalio's Bridgewater Is Crazy About These 15 Stocks. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other stocks Ray Dalio's Bridgewater is crazy about.
The article discusses why Merck & Co., Inc. (MRK) is a favored stock among Ray Dalio's hedge fund, Bridgewater Associates. Merck has shown robust financial performance with a 7% year-over-year revenue increase in Q1 2024, driven by strong sales of its cancer drug Keytruda and vaccines like Gardasil. The company's strategic focus on oncology, with Keytruda expected to remain a significant revenue driver until at least 2028, underpins its attractiveness. Additionally, Merck's pipeline includes promising new treatments, and its recent acquisitions, like Prometheus Biosciences, are aimed at expanding its immunology portfolio. Bridgewater's interest in Merck also reflects confidence in the company's ability to navigate patent expirations and maintain growth through innovation and strategic acquisitions.

Read the Full MSN Article at:
https://www.msn.com/en-us/money/other/why-is-merck-co-inc-mrk-among-the-stocks-ray-dalio-s-bridgewater-is-crazy-about/ar-AA1v7ppq

Like: 👍